A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

Name: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)
Published: 2003
License: Public Domain

AstraZeneca · 2003

ClinicalTrials.gov · Datasets · License: Public Domain · 2003

Open Source ↗

gastroesophageal-reflux-disease

gastroesophageal reflux disease (gerd), gastroesophageal reflux disease, gerd, esomeprazole, heartburn, nexium, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

Related documents